Biology Reference
In-Depth Information
Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B. 2001.
Transient mobilization of human immunode®ciency virus (HIV)-speci®c CD4 T-helper cells
fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1
infection. J Virol 75: 234±241.
Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang
ZQ, Mills R, McDade H, Schuwirth CM, Goudsmit J, Danner SA, Haase AT. 1997. Kinetics of
response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 176: 960±964.
Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson S.
1994. HIV and T cell expansion in splenic white pulps is accompanied by in®ltration of HIV-
speci®c cytotoxic T lymphocytes. Cell 78: 373±387.
Chougnet C, Fowke KR, Mueller BU, Smith S, Zuckerman J, Jankelevitch S, Steinberg SM, Luban
N, Pizzo PA, Shearer GM. 1998. Protease inhibitor and triple-drug therapy: cellular immune
parameters are not restored in pediatric AIDS patients after 6 months of treatment. AIDS 12:
2397±2406.
Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K,
Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch Crovo P, Siliciano RF.
1997. Quanti®cation of latent tissue reservoirs and total body viral load in HIV-1 infection [see
comments]. Nature 387: 183±188.
Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT, Dybul M, Kovacs
JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS. 1999. E¨ect of inter-
leukin-2 on the pool of latently infected, resting CD4
T cells in HIV-1-infected patients re-
ceiving highly active antiretroviral therapy [see comments]. Nat Med 5: 651±655.
Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM. 1989. Detection of
three distinct patterns of T helper cell dysfunction in asymptomatic, HIV-seropositive patients:
Independence of CD4
cell numbers and clinical staging. J Clin Invest 84: 1892±1899.
Clerici M, Seminari E, Suter F, Castelli F, Pan A, Biasin M, Colombo F, Trabattoni D, Maggiolo
F, Carosi G, Maserati R. 2000. Di¨erent immunologic pro®les characterize HIV infection in
highly active antiretroviral therapy-treated and antiretroviral-naive patients with undetectable
viraemia. The Master Group. AIDS 14: 109±116.
Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Facey JM, Whitacre
C, McAuli¨e VJ, Friedman HM, Merigan TC, Reichman RC, Hooper C, Corey L. 1996.
Treatment of human immunode®ciency virus infection with saquinavir zidovudine and zalcita-
bine. N Engl J Med 334: 1011±1017.
CombadiÁre B, Blanc C, Li T, Carcelain G, Delaugerre C, Calvez V, Tubiana R, Debr P, Katlama
C, Autran B. 2000. CD4
Ki67
lymphocytes in HIV-infected patients are e¨ector T cells ac-
cumulated in the G1 phase of the cell cycle. Eur J Immunol 30: 3598±3603.
Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St. Clair M, Fox L, Heath-
Chiozzi M, Leonard JM, Rousseau F, D'Arc Roe J, Martinez A, Kessler H, Landay A. 2000.
Immune reconstitution in the ®rst year of potent antiretroviral therapy and its relationship to
virologic response. J Infect Dis 181: 358±363.
Cooper DA, Emery S. 1999. Latent reservoirs of HIV infection: ¯ushing with IL-2? [news; com-
ment]. Nat Med 5: 611±612.
Dalod M, Harzic M, Pellegrin I, Dumon B, Hoen B, Sereni D, Deschemin JC, Levy JP, Venet A,
Gomard E. 1998. Evolution of cytotoxic T lymphocytes responses to HIV-1 in patients with
symptomatic primary infection on antiretroviral triple therapy. J Infect Dis 178: 61±69.
De Jong MD, De Boeer RJ, De Wolf F. 1997. Overshoot of HIV-1 viraemia after early dis-
continuation of antiretroviral treatment. AIDS 11: F79±F84.
Douek DC, McFarlard RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT,
Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. 1998. Changes
in thymic function with age and during the treatment of HIV infection. Nature 396: 690±
695.
